Market Overview The global market for cell isolation was valued at USD 5.83 billion in 2022 and is projected to reach USD 18.96 billion by 2032, with a compound annual growth rate (CAGR) of 14% during the forecast period. Cell-based therapies, which utilize living cells to address various medical conditions such as cancer, cardiovascular diseases, and neurological disorders, are driving the growth in the market. The increasing prevalence of these disorders, coupled with the growing demand for cell-based therapeutics, is contributing to the rising revenue in the cell isolation products market. Additionally, the need for cell separation products is on the rise due to the development of customized medications and a growing emphasis on regenerative medicine.
One of the key drivers of revenue growth in the cell isolation market is government funding for scientific research. Governments worldwide are making substantial investments in research projects related to stem cells, cancer research, and other areas that necessitate the use of cell isolation products. This funding enables the development of cutting-edge cell separation solutions, fueling the expansion of the market.
Get a sample copy of the Cell Isolation Market report: https://www.reportsanddata.com/download-free-sample/2237
Despite the positive trends, obstacles such as the elevated cost of cell separation products, a shortage of qualified personnel, and ethical concerns related to the utilization of embryonic stem cells may hinder the revenue growth of the market.
Government Regulations:
Cell isolation products in the United States are regulated by the Food and Drug Administration (FDA) through the Center for Biologics Evaluation and Research (CBER). In Europe, the European Medicines Agency (EMA) oversees cell isolation products through its Committee for Advanced Therapies (CAT). The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) is responsible for regulating cell isolation products under the Pharmaceutical Affairs Law. Health Canada's Biologics and Genetic Therapies Directorate (BGTD) regulates cell isolation products in Canada. In China, the State Food and Drug Administration (SFDA) oversees cell isolation products through its Center for Drug Evaluation (CDE). In India, the regulation of cell isolation products falls under the Central Drugs Standard Control Organization (CDSCO). In Australia, cell isolation products are regulated by the Therapeutic Goods Administration. Key Insights Product Type Outlook: The cell isolation market is divided into reagents & kits, instruments, and consumables. In 2021, reagents and kits constituted the largest share of revenue, driven by the increasing demand for efficient cell isolation products. Reagents and kits find applications in drug development, stem cell research, and cancer research. The demand for reagents and kits is expected to rise due to the growing prevalence of chronic diseases and heightened investments in life sciences research and development.
Application Outlook: The cell isolation market's applications include biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, and others. In 2021, biomolecule isolation held the highest revenue share. The market for biomolecule isolation is expanding due to the growing need for pure biomolecules in applications such as drug discovery, proteomics, and genomics.
Cancer research is anticipated to have the highest revenue CAGR during the forecast period. Increased investments in cancer research and development activities, coupled with the rising incidence of cancer, are driving this growth. Cell isolation techniques like flow cytometry, MACS, and fluorescence-activated cell sorting (FACS) are commonly employed in cancer research for the isolation and analysis of cancer cells.
Stem cell research is also expected to experience significant growth, propelled by increased investments in stem cell research and development activities and rising public awareness of regenerative medicine. Various cell isolation techniques, including MACS and FACS, are frequently used for the isolation and study of stem cells.
Regional Outlook: The North American market is expected to lead the global cell isolation industry's rapid growth in the coming years. Factors such as the increasing prevalence of chronic diseases, expanding interest in personalized medicine, and government funding for cell-based research and development contribute to North America's fastest revenue increase. The region benefits from an advanced healthcare system, a sizable research and development sector, and growing investments in biotechnology research.
The Asia Pacific region is anticipated to experience significant growth in the cell isolation market due to rising healthcare costs, a substantial patient base, and increasing interest in cutting-edge cell separation methods. Developing nations like China and India, where the prevalence of chronic diseases is rising, are expected to attract major participants in the cell isolation business due to the region's accessibility to qualified personnel and affordable production costs.
The European market is projected to expand moderately, driven by factors such as increased government spending on life sciences research and development and the prevalence of chronic disorders. Key companies in the cell isolation market, including Thermo Fisher Scientific, STEMCELL Technologies, and Merck KGaA, are based in the European region.
Competitive Landscape: Key players in the cell isolation market include Thermo Fisher Scientific Inc, Beckman Coulter Inc, Miltenyi Biotec GmbH, Bio-Rad Laboratories Inc, STEMCELL Technologies Inc, Becton, Dickinson and Company, GE Healthcare, Merck KGaA, Terumo BCT Inc, Danaher Corporation, and Cell Separation Technologies, Inc.
Strategic Planning:
- In 2021, Thermo Fisher Scientific announced plans to acquire PPD, Inc. for approximately $21.4 billion, enhancing its capabilities in clinical research and laboratory services.
- Beckman Coulter collaborated with Apostle, Inc., a digital health company, in 2020 to develop a platform for blood cell analysis powered by artificial intelligence (AI), aiming to deliver faster and more accurate blood test results.
- Miltenyi Biotec introduced the CliniMACS Prodigy X, a fully automated system for gene transfer and cell isolation, in 2020, simplifying the process of isolating and genetically modifying cells for clinical use.
- Bio-Rad Laboratories launched the S3e Cell Sorter, a high-speed, automated device for cell sorting, in 2020, providing quick and precise cell isolation for various scientific applications.
Explore Trending Reports:
Tetrahydrofuran (THF) Market -https://bhagyashrishewale.blogspot.com/2023/06/tetrahydrofuran-thf-market-is-expected.html
Benzoic Acid Market -https://bhagyashrishewale.blogspot.com/2023/06/benzoic-acid-market-is-expected-to.html
Acrylic Monomers Market -https://bhagyashrishewale.blogspot.com/2023/06/acrylic-monomers-market-to-exceed.html
Bitumen Membranes Market -https://bhagyashrishewale.blogspot.com/2023/06/bitumen-membranes-market-to-exceed.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2237
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release